Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.80
Ask:
1.90
Spread: 0.10 (5.556%)
Market Cap: £2.18m
RDT Live PriceLast checked at - London Stock Exchange

Intraday Rosslyn Data Share Chart

Trading Update

26 Jun 2018 07:00

RNS Number : 5239S
Rosslyn Data Technologies PLC
26 June 2018
 

26 June 2018

 

This announcement contains inside information defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

 

Rosslyn Data Technologies plc

 

("Rosslyn", "RDT", the "Group" or the "Company")

 

Trading Update

For the year ended 30 April 2018

 

 

Rosslyn Data Technologies plc (AIM: RDT), the provider of a leading cloud-based enterprise data analytics platform today announces a trading update for the year ended 30 April 2018.

 

The 2017-2018 financial year has been one of change within the firm. The acquisition of Integrite Ltd ("Integritie") in May 2017 has significantly increased the size of our business and delivered a number of new opportunities with Group revenues for FY18 increased by 94% compared to FY 17 at £7.0m (2017: £3.6m). We are pleased with the business that we have signed during the year although, strategically, we have accepted some lower margin business in relation to a larger contract. We now expect our adjusted loss before tax (excluding one off costs associated with the Integritie acquisition) to be in the region of £1.3 million.

 

We are pleased to report that we have completed the integration of Integritie and onboarded its products on to our RAPid Platform and, during the year, have been able to achieve synergies in excess of the circa £850,000, that we expected at the time of acquisition through both cross selling and operational efficiencies. Furthermore, we have reduced the Group's cost run rate to approximately £7.2m and have identified means to reduce this still further.

 

We ended the year with net cash balances of £0.3M (2017 £0.3M). We continue to manage our cost base and as at 22 June 2018 our net cash balance was £0.7m and are on track to achieve cash flow break-even during the current fiscal year.

 

We have continued to invest in developing our product suite on the RAPid platform, adding new tools and functionality whilst ensuring that the RAPid platform is scalable, user friendly and provides a satisfying user experience for our partners and clients.

 

In addition, during the year, we have invested in the development of an HR analytics product suite utilising the core technologies from our other applications. The ability to implement and operate this within the year demonstrates, we believe, the versatility of the platform.

 

We have added several large clients during the year, including a major FMCG company, a global Fintech company and major Multi-media company, and have continued to expand our partner program, most notably signing a strategic partnership with Dunn & Bradstreet to provide self-service data and analytics to procurement professionals.

 

Our careful execution has been reflected in the Group's key metrics; our client acquisition rate continues at a steady pace and the average cost of acquiring a new client continues to trend lower. These metrics are underpinned by a client churn that remains below 5% of revenues and our committed monthly run rate for FY 19 now stands at in excess of £4.5m, up from £2.5m in FY 18.

 

 

Commenting Roger Bullen, CEO of Rosslyn, said, "I am pleased to present the trading update for the year ended 30 April 2018.

 

The acquisition of Integritie allowed us to increase our offering to the market, whilst providing access to new technologies, introduce automated processes and improve our Artificial intelligence and our Natural Language Processing capabilities across our data analytics suite.

 

We have continued to make our products a scalable, repeatable and cost effective solution for our clients, and have made the products easy to configure and to implement. We have introduced new and simple methods for our clients to implement our products and have made many of the functions, self-service, enabling us to reduce our cost base and to improve the client interaction and adoption. We continue to invest in the development of our talented team, ensuring that our product offering remains market-leading and that we provide the highest levels of service possible to our clients.

 

I am delighted that our revenue base and our cost base are very closely aligned at the year end. This enables us to look to the future with huge optimism. Combining this with the broad pipeline of new business we can see, and the feedback regarding the number of opportunities being provided by our current client base we are extremely excited about the year ahead."

 

 

Rosslyn Data Technologies plc

Roger Bullen,

Chief Executive Officer

 

+44(0)20 7138 3203

+44(0)77 7162 3345

 

Lance Mercereau

Marketing Director

 

 

+44(0)7788 183273

Cenkos Securities -

Nominated Adviser, Broker

Stephen Keys, Camilla Hume

 

+44(0)20 7397 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEEFWIFASEEM
Date   Source Headline
23rd Mar 20215:54 pmRNSExercise of Options
4th Mar 20217:00 amRNSChange of auditor
12th Jan 20217:00 amRNSHalf-year Report
21st Dec 20207:00 amRNSLaunch of CustomsCloudTM product
11th Nov 20207:00 amRNSContract Win
29th Oct 20204:45 pmRNSResult of AGM
30th Sep 20209:20 amRNSNotice of AGM
29th Sep 202010:15 amRNSHolding(s) in Company
28th Sep 20204:33 pmRNSChange of Registered Office
25th Sep 202012:01 pmRNSIssue of Equity
24th Sep 20207:00 amRNSDirector/PDMR Dealing
22nd Sep 20207:00 amRNSAudited Results for the year ended 30 April 2020
1st Sep 20207:00 amRNSBoard Update
28th Aug 20204:42 pmRNSHolding(s) in Company
17th Aug 20207:00 amRNSAppointment of Chief Customer Officer
11th Aug 20209:06 amRNSSecond Price Monitoring Extn
11th Aug 20209:01 amRNSPrice Monitoring Extension
7th Jul 20207:00 amRNSStrengthening client relationships during COVID-19
25th Jun 20207:00 amRNSContract Renewals
16th Jun 20209:01 amRNSDirector/PDMR Options
15th Jun 20207:00 amRNSGrant of Options
12th Jun 20204:13 pmRNSHolding(s) in Company
11th Jun 20203:07 pmRNSHolding(s) in Company
9th Jun 20208:40 amRNSHolding(s) in Company
2nd Jun 20208:07 amRNSHolding(s) in Company
1st Jun 20208:56 amRNSHolding(s) in Company
29th May 20209:43 amRNSHolding(s) in Company
29th May 20208:43 amRNSHolding(s) in Company
28th May 202012:32 pmRNSHolding(s) in Company
28th May 202010:39 amRNSHolding(s) in Company
27th May 202012:06 pmRNSResult of General Meeting
19th May 20208:19 amRNSHolding(s) in Company
18th May 20202:48 pmRNSHolding(s) in Company
15th May 20202:49 pmRNSHolding(s) in Company
7th May 20203:53 pmRNSPlacing to Raise £7.3m and Trading Update
10th Feb 202010:56 amRNSDirector/PDMR Shareholding
4th Feb 20205:26 pmRNSDirector/PDMR Shareholding
15th Jan 20209:17 amRNSPDMR Shareholding
14th Jan 20204:41 pmRNSSecond Price Monitoring Extn
14th Jan 20204:36 pmRNSPrice Monitoring Extension
14th Jan 20207:01 amRNSContract Win
14th Jan 20207:00 amRNSHalf-year Report
8th Jan 20207:00 amRNSContract Wins
11th Dec 20197:00 amRNSTrading Update
26th Nov 20198:57 amRNSHolding(s) in Company
25th Nov 20196:17 pmRNSDirector/PDMR Shareholding
17th Oct 20192:01 pmRNSResult of AGM
17th Oct 20197:00 amRNSBoard Changes
24th Sep 20197:00 amRNSAcquisition
17th Sep 20197:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.